Iveric Bio Inc logo

Iveric Bio Inc Share Price Today (NASDAQ: ISEE)

Iveric Bio Inc share price is $0 & ₹0.00 as on 6 Jul 2023 IST

-39.95

(-100%)

Market is closed - opens 7 PM, 07 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 7 Jul 2023

View live Iveric Bio Inc share price in Dollar and Rupees. Guide to invest in Iveric Bio Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Iveric Bio Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Iveric Bio Inc (ISEE) Key Statistics

in dollars & INR

Previous Close
$39.95
Open
$39.86
Market Capitalization
$5.5B
Today's Volume
$11.0M
Revenue TTM
$0.0
EBITDA
$-228.9M
Earnings Per Share (EPS)
$-1.82
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-55.02%

How to invest in Iveric Bio Inc Stock (ISEE) from India?

It is very easy for Indian residents to invest directly in Iveric Bio Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iveric Bio Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iveric Bio Inc or ISEE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iveric Bio Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iveric Bio Inc shares which would translate to null fractional shares of Iveric Bio Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Iveric Bio Inc, in just a few clicks!

Global Institutional Holdings in Iveric Bio Inc

  • Vanguard Group Inc

    9.90%

  • BlackRock Inc

    7.34%

  • T. Rowe Price Associates, Inc.

    4.94%

  • venBio Select Advisor LLC

    4.93%

  • Deep Track Capital, LP

    4.71%

  • State Street Corporation

    4.08%

Analyst Recommendation on Iveric Bio Inc

Rating
Trend

Hold

    0%Buy

    81%Hold

    18%Sell

Based on 16 Wall street analysts offering stock ratings for Iveric Bio Inc(by analysts ranked 0 to 5 stars)

About Iveric Bio Inc

IVERIC bio, Inc., a biopharmaceutical company, focuses on the discovery and development of novel treatments for retinal diseases with unmet medical needs. The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD); and STAR or OPH2005 that is in Phase 2b clinical trial for the treatment of autosomal recessive Stargardt disease. Its preclinical product candidatures include IC-500, a high temperature requirement A serine peptidase 1 protein inhibitors for the treatment of GA and other age-related retinal diseases. The company also develops OPH2001 that has completed Phase 1/2a clinical trial of various doses of avacincaptad pegol (ACP) administered as a monotherapy for the treatment of GA; OPH2000, which has completed Phase 1/2a clinical trial of various doses of ACP administered in combination with Lucentis for the treatment of wet AMD; OPH2007 that has completed Phase 2a clinical trial for the treatment of wet AMD; and OPH2002, which has completed Phase 2a clinical trial for the treatment of idiopathic polypoidal choroidal vasculopathy. In addition, its minigene programs comprises miniCEP290 program for LCA10; miniABCA4 Program for STGD1; and miniUSH2A Program for usher syndrome type 2A-Related inherited retinal diseases (IRDs). The company was formerly known as Ophthotech Corporation and changed its name to IVERIC bio, Inc. in April 2019. The company was incorporated in 2007 and is based in Parsippany, New Jersey.
Organization
Iveric Bio Inc
Employees
163
CEO
Mr. Glenn P. Sblendorio M.B.A.
Industry
Biotechnology

Important FAQs about investing in ISEE Stock from India :

Can Indians buy Iveric Bio Inc shares?

Yes, Indians can invest in the Iveric Bio Inc (ISEE) from India.

With INDmoney, you can buy Iveric Bio Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Iveric Bio Inc at zero transaction cost.

How can I buy Iveric Bio Inc shares from India?

It is very easy to buy Iveric Bio Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iveric Bio Inc (ISEE) be purchased?

Yes, you can buy fractional shares of Iveric Bio Inc with INDmoney app.

What are the documents required to start investing in Iveric Bio Inc stocks?

To start investing in Iveric Bio Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Iveric Bio Inc?

Today's market capitalisation of Iveric Bio Inc ISEE is 5.5B

Who is the Chief Executive Officer (CEO) of Iveric Bio Inc ?

Mr. Glenn P. Sblendorio M.B.A. is the current Chief Executive Officer (CEO) of Iveric Bio Inc.